Trials / Completed
CompletedNCT00160654
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
A Phase IV, Open-label, Multi-center, Community-based Trial in Asia Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 251 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Community based study assessing safety and efficacy of levetiracetam in partial onset seizures. The optimal dose in daily clinical practice will be used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam | * Pharmaceutical form: oral tablets * Concentration: 500 mg * Route of administration: Oral use |
Timeline
- Start date
- 2003-11-24
- Primary completion
- 2006-12-12
- Completion
- 2006-12-12
- First posted
- 2005-09-12
- Last updated
- 2020-08-19
- Results posted
- 2020-08-19
Locations
29 sites across 6 countries: Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT00160654. Inclusion in this directory is not an endorsement.